These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 7516147)

  • 1. Subunit interaction in B19 parvovirus empty capsids.
    Rosenfeld SJ; Young NS; Alling D; Ayub J; Saxinger C
    Arch Virol; 1994; 136(1-2):9-18. PubMed ID: 7516147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface.
    Rosenfeld SJ; Yoshimoto K; Kajigaya S; Anderson S; Young NS; Field A; Warrener P; Bansal G; Collett MS
    J Clin Invest; 1992 Jun; 89(6):2023-9. PubMed ID: 1376332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candidate recombinant vaccine for human B19 parvovirus.
    Bansal GP; Hatfield JA; Dunn FE; Kramer AA; Brady F; Riggin CH; Collett MS; Yoshimoto K; Kajigaya S; Young NS
    J Infect Dis; 1993 May; 167(5):1034-44. PubMed ID: 8486937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1-VP2 junction regions.
    Saikawa T; Anderson S; Momoeda M; Kajigaya S; Young NS
    J Virol; 1993 Jun; 67(6):3004-9. PubMed ID: 7684458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epitope type-specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19.
    Söderlund M; Brown CS; Spaan WJ; Hedman L; Hedman K
    J Infect Dis; 1995 Dec; 172(6):1431-6. PubMed ID: 7594699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of empty B19 parvovirus capsids by the truncated minor capsid protein.
    Wong S; Momoeda M; Field A; Kajigaya S; Young NS
    J Virol; 1994 Jul; 68(7):4690-4. PubMed ID: 8207846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Most of the VP1 unique region of B19 parvovirus is on the capsid surface.
    Kawase M; Momoeda M; Young NS; Kajigaya S
    Virology; 1995 Aug; 211(2):359-66. PubMed ID: 7544049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions.
    Kajigaya S; Fujii H; Field A; Anderson S; Rosenfeld S; Anderson LJ; Shimada T; Young NS
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4646-50. PubMed ID: 1711206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptides derived from the unique region of B19 parvovirus minor capsid protein elicit neutralizing antibodies in rabbits.
    Anderson S; Momoeda M; Kawase M; Kajigaya S; Young NS
    Virology; 1995 Jan; 206(1):626-32. PubMed ID: 7530397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-helper cell-mediated interferon-gamma, interleukin-10 and proliferation responses to a candidate recombinant vaccine for human parvovirus B19.
    Franssila R; Hedman K
    Vaccine; 2004 Sep; 22(27-28):3809-15. PubMed ID: 15315862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baculovirus expression of erythrovirus V9 capsids and screening by ELISA: serologic cross-reactivity with erythrovirus B19.
    Heegaard ED; Qvortrup K; Christensen J
    J Med Virol; 2002 Feb; 66(2):246-52. PubMed ID: 11782935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The VP1-unique region of parvovirus B19: amino acid variability and antigenic stability.
    Dorsch S; Kaufmann B; Schaible U; Prohaska E; Wolf H; Modrow S
    J Gen Virol; 2001 Jan; 82(Pt 1):191-199. PubMed ID: 11125172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential IgM response to conformational and linear epitopes of parvovirus B19 VP1 and VP2 structural proteins.
    Manaresi E; Zuffi E; Gallinella G; Gentilomi G; Zerbini M; Musiani M
    J Med Virol; 2001 May; 64(1):67-73. PubMed ID: 11285571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Undenatured parvovirus B19 antigens are essential for the accurate detection of parvovirus B19 IgG.
    Kerr S; O'Keeffe G; Kilty C; Doyle S
    J Med Virol; 1999 Feb; 57(2):179-85. PubMed ID: 9892405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins.
    Gigler A; Dorsch S; Hemauer A; Williams C; Kim S; Young NS; Zolla-Pazner S; Wolf H; Gorny MK; Modrow S
    J Virol; 1999 Mar; 73(3):1974-9. PubMed ID: 9971777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant Virus-like Particles of Human Parvovirus B19 with the Internal Location of VP1 Unique Region Produced by
    Shao S; Wang Q; Jin Y; Zhang X; Liu Z; Chen S; Wu H; Yang S; Tang F; Su J; Liang Y; Zhang J; Li Q
    Viruses; 2022 Oct; 14(11):. PubMed ID: 36366508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping of B-cell epitopes on human parvovirus B19 non-structural and structural proteins.
    Tolfvenstam T; Lundqvist A; Levi M; Wahren B; Broliden K
    Vaccine; 2000 Nov; 19(7-8):758-63. PubMed ID: 11115697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assembly of empty capsids by using baculovirus recombinants expressing human parvovirus B19 structural proteins.
    Brown CS; Van Lent JW; Vlak JM; Spaan WJ
    J Virol; 1991 May; 65(5):2702-6. PubMed ID: 1901917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A synthetic parvovirus B19 capsid protein can replace viral antigen in antibody-capture enzyme immunoassays.
    Kock WC
    J Virol Methods; 1995 Sep; 55(1):67-82. PubMed ID: 8576310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human parvovirus B19 VP2 empty capsids bind to human villous trophoblast cells in vitro via the globoside receptor.
    Wegner CC; Jordan JA
    Infect Dis Obstet Gynecol; 2004 Jun; 12(2):69-78. PubMed ID: 15739820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.